Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind Trial of Daridorexant to Prevent Delirium After Heart Surgery

NCT06630390 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT06630390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06630390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind Trial of Daridorexant to Prevent Delirium After Heart Surgery
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Completed
Start date
November 11, 2024
Completion date
February 16, 2025
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative cognitive decline, postoperative delirium